Company Encyclopedia
View More
name
Pro UltrPro M-CPro 400
UMDD.US
News
View More

Perpetual Ltd Lowers Stock Position in Ciena Corporation $CIEN

Perpetual Ltd reduced its holdings in Ciena Corporation by 38.1% in the third quarter, now owning 154,875 shares valued at $22,561,000. This move is part of broader institutional adjustments in Ciena's stock. Ciena's stock opened at $230.42, with a market cap of $32.45 billion. Recent earnings exceeded expectations, with a 20.1% revenue increase year-over-year. Insider transactions include significant stock sales by directors. Analysts have set new price targets for Ciena, reflecting its performance and market conditions.

Market Beat·
US
CIEN
+9.32%
Market Beat·
US
CIEN
+9.32%

If You Invested $100 In Ciena Stock 15 Years Ago, You Would Have This Much Today

Ciena (NYSE:CIEN) has delivered an average annual return of 17.33% over the past 15 years, outperforming the market by 5.41% annually. A $100 investment in Ciena 15 years ago would now be worth $1,098.95, highlighting the power of compounded returns. Ciena's current market cap is $32.44 billion.

benzinga_article·
US
CIEN
+9.32%
benzinga_article·
US
CIEN
+9.32%

Chmn Rothblatt Files To Sell 2,000 Of United Therapeutics Corp [UTHR]

Martine A. Rothblatt, Chairman of United Therapeutics Corp, filed a Form 144 with the SEC to sell 2,000 shares on December 19, 2025, through TD Securities. This sale is part of a prearranged trading plan (10b5-1). Filing Form 144 is required before selling restricted stock, allowing the sale within 90 days of filing.

Reuters·
US
UTHR
+2.00%
Reuters·
US
UTHR
+2.00%

United Therapeutics Executives Engage in Stock Transactions

United Therapeutics executives, Martine A. Rothblatt and Tommy G Thompson, engaged in stock sales. Rothblatt sold 10,000 shares for $5,053,778, while Thompson sold 910 shares for $455,533. These transactions were part of pre-arranged trading plans. Rothblatt's direct ownership is now 130 shares, and Thompson's is 8,480 shares. Both have additional shares held indirectly through trusts.

TradingView·
US
UTHR
+2.00%
TradingView·
US
UTHR
+2.00%

United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares

Martine A. Rothblatt, CEO of United Therapeutics, reported the disposal of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news is for informational purposes and not financial advice.

Reuters·
US
UTHR
+2.00%
Reuters·
US
UTHR
+2.00%
© 2025 Longbridge｜Disclaimer